| Authors: |
Grauers Wiktorin H; Department of Immunology, Genetics and Pathology (IGP), Uppsala University, Uppsala, Sweden., Ekström-Rydén V; Department of Immunology, Genetics and Pathology (IGP), Uppsala University, Uppsala, Sweden.; Department of Oncology, Uppsala University Hospital, Uppsala, Sweden., Ek I; Department of Immunology, Genetics and Pathology (IGP), Uppsala University, Uppsala, Sweden., Eriksson E; Department of Immunology, Genetics and Pathology (IGP), Uppsala University, Uppsala, Sweden.; Lokon Pharma AB, Uppsala, Sweden., Lövgren T; Department of Immunology, Genetics and Pathology (IGP), Uppsala University, Uppsala, Sweden., Bernedal Nordström C; Lokon Pharma AB, Uppsala, Sweden., Sandin LC; Lokon Pharma AB, Uppsala, Sweden., Patel MR; Baylor College of Medicine, McNair Campus, Houston, TX, USA., Hamid O; The Angeles Clinic and Research Institute, A Cedars Sinai Affiliate, Medical Oncology, Los Angeles, CA, USA., Ullenhag G; Department of Immunology, Genetics and Pathology (IGP), Uppsala University, Uppsala, Sweden.; Department of Oncology, Uppsala University Hospital, Uppsala, Sweden., Loskog A; Department of Immunology, Genetics and Pathology (IGP), Uppsala University, Uppsala, Sweden. angelica.loskog@igp.uu.se.; Lokon Pharma AB, Uppsala, Sweden. angelica.loskog@igp.uu.se. |
